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Abstract
Introduction: Liver X receptors (LXRs) are nuclear receptors that function as
cholesterol sensors and regulate cholesterol homeostasis. High cholesterol has been
recognized as a risk factor in asthma; however, the mechanism of this linkage is not
known.
Methods: To explore the importance of cholesterol homeostasis for asthma, we
investigated the contribution of LXR activity in an ovalbumin- and a house dust
mite-driven eosinophilic asthma mouse model.
Results: In both models, airway inflammation, airway hyper-reactivity, and goblet
cell hyperplasia were reduced in mice deficient for both LXRa and LXRb isoforms
(LXRa/b/) as compared to wild-type mice. Inversely, treatment with the LXR
agonist GW3965 showed increased eosinophilic airway inflammation. LXR activity
contributed to airway inflammation through promotion of type 2 cytokine
production as LXRa/b/ mice showed strongly reduced protein levels of IL-5
and IL-13 in the lungs as well as reduced expression of these cytokines by CD4þ
lung cells and lung-draining lymph node cells. In line herewith, LXR activation
resulted in increased type 2 cytokine production by the lung-draining lymph
node cells.
Conclusions: In conclusion, our study demonstrates that the cholesterol regulator
LXR acts as a positive regulator of eosinophilic asthma in mice, contributing to
airway inflammation through regulation of type 2 cytokine production.
Introduction
Asthma is a chronic disease of the airways that presents as
recurrent episodes of wheezing, shortness of breath, chest
tightness, and coughing. These symptoms are associated
with airway inflammation, airway remodeling, and airway
hyper-reactivity (AHR). Asthma is a heterogeneous disease
and can be subdivided into endotypes based on clinical
characteristics, on pathobiological characteristics, including
eosinophilic and neutrophilic inflammation, and on factors
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that associate with or trigger asthma. Early-onset allergic
asthma is the most frequent type of asthma and is associated
with IgE production against identifiable allergic triggers and
eosinophilic inflammation driven by Th2 cell populations
[1, 2]. According to the World Health Organization, 235
million people currently suffer from asthma, most of them
children (www.who.int/mediacentre/factsheets/fs307/en/).
The prevalence of asthma is highest in developed countries,
but the disparity is narrowing due to a rising prevalence in
low- and middle-income countries as they adopt a more
Western-type lifestyle [3]. One of the main objectives in the
strategy of the World Health Organization to prevent and
control asthma is to analyze its determinants and monitor
trends. Dyslipidemia, characterized by high cholesterol levels
in the blood, has gained interest as a risk factor for asthma.
This is due to the fact that several epidemiological studies
have shown a positive association between dyslipidemia and
asthma symptom severity both in children and adults [4–10].
In line herewith, hypercholesterolemia in mice has been
shown to result inmore severe allergen-induced eosinophilic
airway inflammation as well as in increased AHR and goblet
cell hyperplasia [11, 12].
Liver X receptors (LXRs) are a subset of nuclear receptors
that regulate whole body and cellular lipid and cholesterol
metabolism [13]. While the inducible isoform, LXRa, is
highly expressed in organs involved in lipid metabolism,
such as the liver, adipose tissue, and macrophages, the LXR
b-isoform is expressed ubiquitously at a moderate level.
LXRs form heterodimers with the retinoid X receptor and
regulate the expression of genes containing LXR-response
elements. LXRs act as cholesterol sensors that upon binding
of oxidized cholesterol derivatives promote transcription of
genes involved in reverse cholesterol transport, such as the
lipid transporters ATP-binding cassette transporter A1 and
G1 (ABCA1/ABCG1), lipid carrier proteins like apolipopro-
tein E (apoE), and receptors involved in lipid uptake such as
scavenger receptor BI (SR-BI) and low-density lipoprotein
receptor (LDL-R). Besides cholesterol homeostasis, LXRs
also regulate fatty acid metabolism through upregulation of
the transcription factor sterol regulatory element-binding
protein 1c (SREBP1c) and several lipogenic enzymes such as
stearoyl coenzyme A desaturase-1 (SCD1). Apart from their
role in lipid and cholesterol metabolism, LXRs are
increasingly emerging as inflammatory mediators, either
repressing or promoting innate and adaptive immune
responses in different infectious and inflammatory dis-
eases [14–17]. Owing to their ability to sense increased
cholesterol levels and to modulate inflammatory signaling,
LXRs pose as a potential regulator at the basis of the positive
association between cholesterol and asthma. However,
several studies have documented an anti-inflammatory
rather than pro-inflammatory role for LXR in allergic
disorders. LXR activation has been shown to negatively
regulate IgE production [18] and to reduce IL-6 production
by IgE-stimulated murine mast cells [19]. Also airway
remodeling and AHR appear to be modulated by LXR
activity. In a first study, LXR agonist treatment of BALB/c
mice resulted in an increase in AHR to inhaled methacholine
together with a thickening of the airway smooth muscle
mass [20]. In contrast, a more recent study showed a
decrease in AHR to inhaled methacholine upon LXR
activation. This coincided with a reduced airway smooth
muscle thickness and reduced goblet cell hyperplasia [21].
This discrepancy in the role of LXR in asthma highlights the
need for an in-depth study investigating the contribution of
LXR activity to the development of allergic eosinophilic
asthma.
In the present study, we investigated the role of LXR in
eosinophilic airway inflammation by means of an OVA- and
a house dust mite (HDM)-induced asthma mouse model. In
both models, we found that eosinophilic airway disease is
attenuated in mice deficient for both LXR isoforms. This
attenuation was accompanied by a reduced AHR to inhaled
methacholine along with a reduced production of type 2
cytokines in the lungs and the lung-draining lymph nodes
(LNs). In addition, we demonstrate that LXR activation by
administration of the LXR agonist GW3965 leads to an
increase in eosinophilic airway inflammation and type 2
cytokine production by mediastinal LN cells. We conclude
that LXR activity positively contributes to eosinophilic
airway inflammation as well as to the expression of type 2
cytokines.
Material and Methods
Mice
C57BL/6 LXRa/, LXRb/, and LXRa/b/mice [22]
were bred in the animal facilities of the Ghent University.
Experiments were carried out using age- and sex-matched
8–12-week-old mice. Mice were housed in specific
pathogen-free conditions in individually ventilated cages
in a controlled day-night cycle and given food and water ad
libitum. All experiments were approved by the animal
ethics committee of Ghent University, in accordance with
European guidelines.
OVA/alum mouse asthma model
Mice were sensitized to OVA (grade V) (Sigma, St. Louis,
MO) by intraperitoneal (i.p.) injection of 100mg OVA
adsorbed on 1mg alum (Sigma) in 0.5mL endotoxin-free
PBS (Lonza, Basel, Switzerland) on days 0 and 7. Starting
from day 21, mice were challenged for 30min with an
aerosolized solution of 1% OVA (grade III) (Sigma) in
endotoxin-free PBS for 2–8 consecutive days. Mice that were
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sensitized with OVA/alum and challenged with PBS served
as controls.
HDM mouse asthma model
Mice were sensitized to HDM by intratracheal (i.t.)
instillation of 1mg HDM extracts (Greer Laboratories,
Lenoir, NC) on days 0 and 14. Starting from day 21, mice
were challenged intranasally with 10mg HDM for 4
consecutive days. Mice that were sensitized and challenged
with PBS served as controls. In the LXR agonist studies, mice
were treated with 20mg/kg GW3965 (Cayman Chemicals,
Ann Arbor, MI) by oral gavage 2 h before intranasal HDM
challenge.
Collection of samples
Mice were euthanized by i.p. injection of Nembutal (Medini
NV, Oostkamp, Belgium) 24 h after the indicated allergen
challenge. Blood was collected by bleeding of the orbital
sinus and captured in an eppendorf tube for serum
preparation after overnight clotting at 48C. Bronchoalveolar
lavage (BAL) was performed with 4 1mL HBSS (Life
Technologies, Thermo Fisher Scientific, Waltham, MA)
supplemented with 0.05mM EDTA. Supernatant from the
first 0.5mL bronchoalveolar lavage fluid (BALF) was used
for cytokine analysis. After BAL, the mediastinal LNs and the
lungs were isolated. Depending on the read-out, lungs were
either put in 4% paraformaldehyde for histological analysis,
kept in tissue culture medium for CD4þ T cell isolation, or
snap-frozen in liquid nitrogen for RNA extraction.
Flow cytometry
Differential cell counting was performed by flow cytometry.
Cells were labeled for the surface markers CD3 (145-2C11),
SiglecF (RP/14), CD11c (HL3), CD4 (RM4-5), Ly6G (1A8)
(BD Biosciences, San Jose, CA), CD8 (53–6.7), CD11b
(M1/70) (BD Biosciences), and CCR3 (83101) (R&D
Systems, Minneapolis, MN). Measurements were performed
on a LSRII flow cytometer (BD Biosciences) and analysis was
carried out with BD FACS Diva software. The gating strategy
that was used to distinguish the different leukocyte cell
populations is shown in Supplementary Figure S1.
Measurement of AHR
For invasive measurement of dynamic airway elastance,
compliance, and resistance, mice were anesthetized with
urethane, tracheotomized, and intubated with an 18G
catheter.Natural breathingwas stoppedusingd-tubocurarine,
followed bymechanical ventilation with a Flexivent apparatus
(SCIREQ, Montreal, Canada). Respiratory frequency was set
at 120 breaths/min with a tidal volume of 0.2mL and a
positive-end expiratory pressure of 2mL H2O was applied.
Increasing concentrations of methacholine (0–800mg/kg)
were administered via the jugular vein. Dynamic elastance,
compliance, and resistance were recorded after a standardized
inhalation maneuver given every 10 sec for 2min. Baseline
resistance was restored before administering the subsequent
dose of methacholine.
Gene expression in total lung cells and lung CD4þ
cells
To assess relative mRNA expression levels in total lung cells,
lungs were first snap-frozen in liquid nitrogen and then
individually crushed using a pre-cooled mortar. Total RNA
was prepared with TRIsure (Bioline, Taunton, MA)
according to the manufacturer’s instructions. To measure
cytokine expression levels in lung CD4þ cells, lung tissue was
pooled per group and single cell suspensions were prepared
by digestion of minced tissue with 1mg/mL collagenase type
IV (Sigma) and 150U/mL DNaseI (Roche Life Science,
Basel, Switzerland) for 30min at 378C. The digest was passed
through a 70mm cell strainer, and RBCs were lysed with
ACK lysis buffer. The CD4þ cell fraction was isolated
through magnetic cell sorting with CD4 (L3T4) MicroBeads
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to
the manufacturer’s instructions. Total RNA was prepared
with the RNeasy Mini Kit (Qiagen, Hilden, Germany). From
the RNA, complementary DNA was prepared with Super-
script II (Invitrogen, Thermo Fisher Scientific). Quantita-
tive-PCRwas performedwith SYBRGreenmix (Bioline) on a
Roche LightCycler 480 system (Applied Biosystems, Thermo
Fisher Sceintific). The sequences of the forward and reverse
primers (Invitrogen) that were used are as follows: Il-5 (50-
ACATGCACCATTGCCACTAG-30 and 50- AATAGAAGTG
GGCTTACTAGAG-30), Il-4 (50-CCATGCTTGAAGAAGAA
CTCTAG TGTT-30 and 50-GACTCATTCATGGTG CAGCT
TATC-30), Il-13 (50-TCAGCCATGAAAT AACTTATTGTT
TTGT-30 and 50-CCTT GAGTGTAACAGGCCATTCT-30),
Gata3 (50-GG CAGAAAGCAAAATGTTTGCT-30 and 50-TG
AGTCTGAATGGCTTATTCACAAAT-30), Stat6 (50-GGGT
GTTAATGCTCGAATGTGATA-30 and 50-CACAATGTCT
CTATGTTTCT GTATGTTGAG-30), Abca1 (50-CGCAAG-
CATATGCCTCAT-30 and 50-C CCATTACATAACACATG
GCT-30), Srebp1c (50-AGGCCATCGACTACATCCG-30 and
50-TCCATAGAC ACATCTGTGCCTC-30), and Scd1 (50-T
GGGGCTGCTAATCTCTGGG TGTA-30 and 50-G GCTTT
ATCTCTGGGGTGGGTTTG-30). Expression data were nor-
malized to the expression levels of housekeeping genes Tbp
(50-TCTACCGTGAATCTTGGCTGTAAA-30 and 50-TTCTC
ATGATGACTGCAGCAAA-30) and Rpl13a (50-CCTGCTGC
TCTCAAGGTTGTT-30 and 50-TGGCTGTCACTGCCTGG-
TACTT-30).
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Ex vivo restimulation of mediastinal LN cells
Mediastinal LNs were isolated and pooled per group or kept
separate, as indicated. A single cell suspension was obtained
by passing the LNs through a 70mm cell strainer. Cells were
seeded in round bottom 96well plates at 1 106 cells per well
and restimulated either with PBS or with 15mg/mL HDM.
After 48 h, culture supernatants were collected for luminex
analysis (Bio-Rad, Hercules, CA).
Cytokine, chemokine, and allergen-specific IgE
measurements
Cytokines and chemokines were captured with luminex
beads (Bio-Rad) and the cytokine levels were measured on a
Luminex Bioplex suspension array system (Bio-Rad)
according to the manufacturer’s instructions. CCL-11 levels
in the BALF were measured using a mouse CCL-11/Eotaxin
ELISA (R&D Systems). OVA-specific IgE levels in serum and
BALF were determined by ELISA. Briefly, plates were coated
with OVA (grade V) (Sigma) and incubated with a twofold
serial dilution of the serum or BALF samples. Allergen-
bound IgE antibodies were detected with an HRP-
conjugated rat anti-mouse IgE detection antibody (Southern
Biotech, Birmingham, AL). Plates were developed with TMB
substrate (BD OptEIA, BD Biosciences) and measurements
were made at 450/655 nm using a microplate reader after
stopping the reaction with sulphuric acid. The IgE titer was
defined as the dilution factor of the sample at a specific
absorbance value in the linear area of the dilution curve.
Histological analysis
Lungs were fixed with 4% paraformaldehyde, embedded in
paraffin, cut into 5mm sections, and stained with periodic
acid–Schiff (PAS) (Sigma) to identify mucus-containing
cells. The numerical scores for the abundance of PAS-
positive mucus-containing cells in each bronchus were
determined as follows: 0, less than 5% PAS-positive cells; 1,
5–25%; 2, 25–50%; 3, 50–75%; 4, >75% as described by
Tanaka et al. [23].
Statistics
For all experiments apart from AHR studies, data are shown
as mean SD. Statistical analysis between two groups was
performed using a Mann–Whitney U test and between
multiple groups using a Kruskal–Wallis test followed by a
post hoc Dunn’s test. Significant P-values were ranked as
P< 0.05 (), P< 0.01 (), and P< 0.001 ().
For AHR studies, the dynamic airway elastance,
compliance, and resistance values were ln-transformed
and analyzed as repeated measurements using the residual
maximum likelihood (REML) as implemented in Genstat
v17 [24]. A linear mixed model was fitted to the data, with
methacholine dosages set as not-equally spaced. The
antedependence correlation structure of order 1 or 2 was
selected as best model fit for each of the three data sets
based on a likelihood ratio test (LRT) statistic and the
Aikake Information Coefficient (AIC). Significance of the
fixed main and interaction effects was assessed by an F-test.
Significances of contrasts between particular genotype
and methacholine dose combinations were assessed by
an F-test. Data are shown as mean SE. Significant
P-values were ranked as P< 0.05 (), P< 0.01 (), and
P< 0.001 ().
Results
LXR is a positive regulator of OVA-induced
eosinophilic airway disease
To investigate the potential role of LXRs in allergic
eosinophilic asthma, we examined LXR-deficient mice in
an OVA-induced eosinophilic asthma mouse model. Mice
were first sensitized against OVA by i.p. injection together
with aluminium hydroxide (alum) and then exposed to
nebulized OVA for 6 consecutive days, which resulted in
inflammatory cell infiltration in the lungs. Mice deficient for
both LXR isoforms (LXRa/b/) showed a decrease in
overall airway inflammation, with a twofold reduction in
eosinophil numbers in the BAL as compared to wild-type
(WT) mice (Fig. 1A). This reduction in eosinophilic
inflammation was associated with the loss of both the
LXR a- and b-isoforms since eosinophil numbers in the
lungs of LXRa/ and LXRb/ mice were either identical
or only slightly decreased as compared toWTmice (Fig. 1A).
Because loss of a single isoform was functionally compen-
sated by the other, all following experiments using this
model were performed on LXRa/b/ mice.
The reduced airway eosinophilia in LXR-deficient mice
was apparent already early during the allergic inflammatory
response, after two consecutive aerosol exposures, and
persisted at all time-points assessed (Fig. 1B). In contrast to
the diminished eosinophil numbers early in the inflamma-
tory response, CD4þ T cell numbers in the BAL of LXRa/
b/ mice showed reduced numbers only after six OVA
aerosols (Fig. 1B).
Next, we assessed AHR of OVA challenged WT and
LXRa/b/ mice by measuring dynamic resistance,
elastance, and compliance of the airways to methacholine
24 h after the last of six daily OVA aerosols. The airway
resistance seen in OVA-challenged LXR-deficient mice was
significantly lower as that seen in OVA-challengedWTmice,
indicative of reduced AHR upon loss of LXR activity
(Fig. 1C). In accordance with reduced airway resistance,
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OVA-challenged LXRa/b/ mice also displayed a
reduction in airway elastance and an increase in airway
compliance, indicative of a reduced stiffness of the lungs
(Fig. 1C). Another main characteristic of asthma is airway
narrowing due to excessive mucus production, resulting
from goblet cell hyperplasia. In accordance with reduced
airway inflammation and reduced AHR, also the number
of mucus-producing goblet cells was diminished in OVA
challenged LXR-deficient mice in comparison to WT mice,
as determined by lung histologic PAS staining (Fig. 1D).
Remarkably, when assessing peripheral and local OVA-
specific IgE antibodies, an opposite trend toward increased
reactivity was observed. As shown in Figure 1E, LXRa/b/
 mice showed increased serum levels of OVA-specific IgE
compared to WTmice, reaching statistical significance at six
and eight OVA challenges. Local IgE levels in the BALF were
lower as compared to those in the serum and were detectable
only after six and eight OVA challenges. Similarly to serum,
at these time points, increased IgE levels were observed for
LXRa/b/ mice in comparison to WT mice (Fig. 1E).
Figure 1. LXR-deﬁcient mice display reduced airway inﬂammation, airway hyper-reactivity (AHR) and goblet cell hyperplasia in OVA-induced asthma
as compared to wild-type (WT) mice. WT, LXRa/, LXRb/, and LXRa/b/mice were sensitized against OVA and subsequently challenged with
aerosolized OVA. (A) Differential cell counts in the bronchoalveolar lavage (BAL) after exposure to six OVA aerosols measured by ﬂow cytometry.
(B) Eosinophils and CD4þ T cells in the BAL assessed by ﬂow cytometry after 2–8 consecutive OVA aerosols. (C) Dynamic airway resistance [R],
elastance [E], and compliance [C] was determined in mice exposed to increasing doses of methacholine after exposure to six OVA aerosols.
(D) Mucus production evaluated by PAS staining of lung parafﬁn sections of mice exposed to six OVA aerosols. (E) OVA-speciﬁc IgE titer in serum and
bronchoalveolar lavage ﬂuid measured by ELISA. (A) A Kruskal–Wallis test followed by a post hoc Dunn's test was used. (B, D, and E) Statistical
analysis between two groups was performed using a Mann–Whitney U test. Data are shown as mean SD, n¼ 5 to 7 mice per group. The results
show one representative experiment out of at least two independent experiments. (C) The repeated measures in dynamic AHR of three independent
experiments were analyzed by residual maximum likelihood. Data are shown as mean SE, n¼ 5–7 mice per group. Signiﬁcant P-values were ranked
as P< 0.05 (), P< 0.01 (), and P< 0.001 ().
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LXR is a positive regulator of HDM-induced
eosinophilic airway disease
In a second approach, we investigated the role of LXR activity
in a mouse asthma model driven by the natural allergen
HDM [25]. In this model, mice were first sensitized to the
allergen by i.t. instillation and subsequently challenged four
times with HDM administered by the intranasal route.
Analysis of the airway inflammatory response revealed an
even stronger LXR dependency as compared to the OVA-
driven mouse model. A sevenfold decrease in eosinophil
numbers was observed in the BAL of mice deficient for either
the LXR b-isoform alone (LXRb/) or for both LXR
isoforms (LXRa/b/) as compared toWTmice (Fig. 2A),
indicating a dependency on the LXR b-isoform. Aside from a
reduction in airway inflammation, LXRa/b/ mice also
displayed a reduced number of mucus-producing goblet cells
in the airways (Fig. 2B) and reduced AHR (Fig. 2C). LXR-
deficient mice challenged with HDMdisplayed a significantly
lower airway resistance upon exposure to methacholine
together with a trend toward a decrease in airway elastance
and an increase in airway compliance (Fig. 2C). Finally, serum
levels of HDM-specific IgE were also measured but were too
low for reliable titer determination (data not shown).
LXR deficiency is associated with reduced type 2
cytokine production in allergen-challenged lungs
In order to verify to what extent LXR deficiency affected local
production of type 2 cytokines early in the OVA-driven
inflammatory response, we quantified cytokine and chemo-
kine levels in the BALF after twoOVA aerosols. Protein levels
of the distinctive type 2 cytokines, IL-5, and IL-13, but not of
IL-4, were readily detectible in the BALF of OVA-challenged
WT mice (Fig. 3A). Strikingly, in LXRa/b/ mice, a
pronounced drop in IL-5 and IL-13 protein levels was
observed, showing protein levels close to those in unchal-
lenged mice. Next to a decreased type 2 cytokine production
in the BALF, LXRa/b/mice also showed reduced levels
of CCL-4 (RANTES) and CCL-11 (eotaxin-1), chemokines
involved in eosinophil recruitment to the asthmatic lung
(Fig. 3B).
Also for the HDM-driven asthma model, we assessed
the effect of LXR deficiency on the production of type 2
Figure 2. LXR-deﬁcient mice display reduced airway inﬂammation, goblet cell hyperplasia, and airway hyper-reactivity (AHR) in house dust mite (HDM)-
induced asthma as compared to wild-type (WT) mice. WT, LXRa/, LXRb/, and LXRa/b/ mice were sensitized against HDM and subsequently
challenged intranasally with HDM for 4 consecutive days. (A) Differential cell counts in the bronchoalveolar lavage measured by ﬂow cytometry.
(B) Mucus production evaluated by PAS staining of lung parafﬁn sections. (C) Dynamic airway resistance [R], elastance [E], and compliance [C] was
measured in mice exposed to increasing doses of methacholine after HDM challenge. (A) A Kruskal–Wallis test followed by a post-hoc Dunn's test
was used. (B) Statistical analysis between two groups was performed using a Mann–Whitney U test. Data are shown as mean SD, n¼ 5–7 mice per
group. The results show one representative experiment out of at least two independent experiments. (C) The repeated measures in dynamic AHR
of one independent experiment were analyzed by residual maximum likelihood. Data are shown as mean SE, n¼ 5–7 mice per group. Signiﬁcant
P-values were ranked as P< 0.05 () and P< 0.01 ().
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cytokines and eosinophil-recruiting chemokines in the
lungs. After four consecutive daily HDM challenges, we
observed slightly reduced IL-5 and strongly reduced IL-13
protein levels in the BALF of LXRa/b/ mice as
compared to WT mice (Fig. 3C). Likewise, LXR-deficient
mice displayed strongly diminished CCL-4 levels in the
BALF (Fig. 3D). Protein levels of IL-4 and CCL-11 were not
detectable.
Loss of LXR activity is associated with reduced
type 2 cytokine expression in allergen-challenged
lungs and lung-draining lymph nodes
In addition to reduced type 2 cytokine protein levels in
OVA-driven asthma, diminished mRNA expression levels of
Il-5, Il-13, and Il-4were observed in CD4-enriched lung cells
from LXRa/b/ mice (Fig. 4A). In contrast, the mRNA
levels of the Th2-regulating transcription factors Gata3 and
Stat6 were unaltered betweenWT- and LXR-deficient CD4þ
lung cells (Fig. 4A), thus indicating that the nature of the Th2
cell response was not affected by LXR deficiency. The lack of
mRNA expression of Th1- and Th17-associated cytokines
and transcription factors (data not shown) further corrobo-
rated the unaltered Th2 nature of the allergic response in
LXRa/b/ mice.
In the HDM-driven asthma model, we found that the
lung-draining mediastinal LN cells of HDM-sensitized
and challenged LXRa/b/ mice produced less type 2
cytokines upon ex vivo HDM restimulation as compared
to LN cells from WT mice (Fig. 4B). In addition, we did
not observe a bias toward the Th17 effector cytokine IL-17
or Th1 effector cytokine IFNg (data not shown), thus
revealing that also in this model the nature of the Th2
response is not changed.
Treatment with a synthetic LXR agonist increases
HDM-induced eosinophilic airway inflammation
Next, we investigated the effect of LXR activation on
eosinophilic airway inflammation. Therefore, we treated
mice by oral gavage with 20mg/kg of the highly selective
LXR agonist, GW3965. This treatment resulted in a
pronounced upregulation of LXR target genes (Abca1,
Srebp1c, and Scd1) in the lungs (Fig. 5A), proving that the
agonist reached the lungs and was biologically active.
Accordingly, we combined LXR agonist treatment with the
HDM-induced asthmamodel in order to verify the impact of
an increased LXR activity on the airway inflammatory
response. As shown in Figure 5B, an increased LXR activity
prior to HDM allergen exposure significantly increased
the strength of the airway inflammation as indicated by the
increased total cell numbers and eosinophils present in
the BAL of the treated mice. Consistent with a stronger
Figure 3. LXR-deﬁcient mice show decreased type 2 cytokine and
chemokine levels in the lungs as compared to wild-type (WT) mice in
OVA- and house dust mite (HDM)-induced asthma. (A) Cytokine and
(B) chemokine levels in the bronchoalveolar lavage ﬂuid (BALF) of WT
and LXRa/b/ mice after 2 consecutive OVA aerosols. (C) Cytokine
and (D) chemokine levels in the BALF of WT and LXRa/b/mice after
four intranasal HDM challenges. Cytokine and chemokine levels were
determined by luminex analysis or ELISA. Data are shown as mean SD,
n¼ 5–7 mice per group. The results show one representative experiment
out of two independent experiments. Statistical analysis between
two groups was performed using a Mann–Whitney U test. Signiﬁcant
P-values were ranked as P< 0.05 () and P< 0.01 ().
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eosinophilic inflammation upon LXR activation, the
mediastinal LN cells of the mice produced higher levels of
the type 2 cytokines IL-5, IL-4, and IL-13 after ex vivo HDM
restimulation (Fig. 5C).
Discussion
In this study, we addressed the role of the cholesterol-sensing
nuclear receptor LXR in the pathogenesis of eosinophilic
allergic asthma. To this end, we employed a mouse asthma
model based on sensitization to the model allergen, OVA, in
the presence of the Th2-skewing adjuvant alum followed by
OVA aerosol challenges. We showed that in this mouse
model, a significantly attenuated airway inflammation is
seen in mice that are deficient for both the a- and b-isoform
of LXR. This attenuated airway response was partially lost
with single LXRa and LXRb deficiency, indicative of a
functional redundancy for both LXR isoforms in this asthma
model. A similar observation was made in a mouse asthma
model based on sensitization and challenge with HDM, a
naturally occurring allergen [25]. However, in the HDM-
induced asthma model, the LXR a-isoform could not
compensate for the loss of LXRb, thus indicating that here
the contribution of LXR activity to airway inflammation was
driven primarily by the b-isoform. Although LXR-deficient
mice represent a good tool to investigate the function of LXR
in disease pathogenesis, the use of LXR agonists is
complementary to these studies and serves as a strategy to
increase LXR activity. Here, we showed that an increased
LXR activity directly impacted on the airway allergic
response. Administration of the highly selective LXR agonist,
GW3965, prior to HDM challenge resulted in increased
eosinophilic airway inflammation. Both approaches—loss
versus gain of LXR activity—corroborate a role for the
cholesterol-sensing nuclear receptor LXR as a positive
regulator of airway inflammation in asthma.
Aside from contributing to airway inflammation, we
also demonstrated that loss of LXR activity reduced
excessive mucus production and AHR, cardinal features of
asthma. In both OVA-induced and HDM-induced asthma,
LXRa/b/ mice displayed strongly diminished num-
bers of mucus-producing goblet cells and showed a
reduced dynamic airway resistance to methacholine. Our
findings are in line with a study showing increased AHR to
inhaled methacholine in OVA-challenged BALB/c mice
upon oral treatment with the LXR agonist GW3965 [20].
In contrast, another study in OVA-challenged BALB/c
mice showed decreased AHR to inhaled methacholine
upon oral treatment with the LXR agonist T0901317 [21].
The cause of these different outcomes could be the use of
Figure 4. LXR-deﬁcient mice show decreased Th2 cytokine expression in the lungs and lung-draining lymph nodes as compared to wild-type (WT) mice
in OVA-induced and house dust mite (HDM)-induced asthma. (A) mRNA expression levels of Th2-associated cytokines (Il-5, Il-13, Il-4) and transcription
factors (Gata3 and Stat6) in the CD4þ cells of the lungs of WT and LXRa/b/mice after two consecutive OVA aerosols. Lung cells were pooled per
group before CD4þ enrichment and relative mRNA expression levels were determined in triplicate by qPCR. (B) Cytokine production by mediastinal LN
cells of WT and LXRa/b/mice after four intranasal HDM challenges. Mediastinal LN cells were pooled per group and restimulated in quadruplicate
with HDM for 48 h. Cytokine levels were measured by luminex analysis. Data are shown as mean SD, n¼ 3–7 mice per group. The results show one
representative experiment out of two independent experiments.
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distinct synthetic LXR agonists. Whereas the GW3965
agonist is highly selective for LXR, the T0901317 agonist
can also activate other nuclear receptors such as the
Farnesoid X Receptor, indicating that the observations in
this study might be LXR-independent. Collectively, our
findings identify LXR as a nuclear receptor contributing to
eosinophilic airway inflammation and the pathogenesis of
allergic asthma.
An important feature of allergic asthma is the production
of allergen-specific IgE antibodies. Applying the OVA/alum-
based model, we here show OVA-specific IgE levels in
serum and BALF to be increased in LXRa/b/ mice.
This observation is in line with previous reports document-
ing a reduction in IgE levels upon LXR activation in OVA/
alum-based models [18, 21]. Taken together, our data
suggest that LXR activity differentially impacts on distinct
branches of the allergic response; on the one hand
promoting eosinophilic airway inflammation while on the
other hand repressing IgE antibody production and atopy.
Eosinophilic inflammation in asthmatic lungs is mainly
driven by CD4þ Th2 cells through production of the type 2
cytokines IL-4, IL-5, and IL-13. LXR deficiency strongly
affected type 2 cytokine production in both mouse models,
marked by reduced protein levels of IL-5 and IL-13 in the
BALF of LXRa/b/ mice as compared to WT mice.
Analysis of the reactivity and helper profile of CD4-enriched
cells from the lung of OVA challenged LXR-deficient mice
showed lower mRNA levels of Th2 cytokines in spite of
unaltered expression of Th2 differentiation markers and this
while the nature of the T helper cell response was not
affected. A reduction in the number of CD4þ T cells in the
BAL of LXRa/b/mice was seen only after six challenges
Figure 5. LXR agonist treatment increases eosinophilic airway inﬂammation and type 2 cytokine production in house dust mite (HDM)-induced asthma.
(A) mRNA expression levels of LXR target genes in the lungs 6 h after carrier or GW3965 treatment by oral gavage. (B) Wild-type mice were sensitized
against HDM and subsequently challenged intranasally with HDM for 4 days. Two hours before intranasal HDM challenge, micewere treatedwith carrier
or GW3965 administered by oral gavage. Differential cell counts in the bronchoalveolar lavage were measured by ﬂow cytometry. (C) Mediastinal lymph
nodes were isolated and cells were restimulated with HDM for 48 h. Cytokine levels were measured by luminex analysis. Statistical analysis between two
groups was performed using a Mann–Whitney U test. Data are shown as mean SD, n¼ 7–10 mice per group. The results show one representative
experiment out of two independent experiments. Signiﬁcant P-values were ranked as P< 0.05 (), P< 0.01 (), and P< 0.001 ().
LXRs stimulate eosinophilic asthma in mice M. Smet et al.
358 © 2016 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd.
with nebulized OVA, whereas decreased type 2 cytokine
levels were observed already after two OVA challenges. This
difference in kinetics suggests that type 2 cytokine produc-
tion was affected directly by LXR activity rather than
indirectly through a defective expansion of type 2 cytokine-
producing CD4þ T cells. These observations therefore point
toward a reduced Th2 cell reactivity as basis of the reduced
type 2 cytokine levels in the BALF of LXR-deficient mice. In
the HDM-driven asthma model, lung-draining mediastinal
LN cells restimulated ex vivo with HDM showed reduced
type 2 cytokine expression, again in spite of an unaltered
expression of Th2 cell differentiation markers. Inversely,
mediastinal LN cells showed an increased production of type
2 cytokines upon an increase of LXR activity induced by
treatment with the LXR agonist GW3965. These results all
point toward LXR exerting a positive regulatory role on
eosinophilic inflammation by acting as a transcriptional
regulator of type 2 cytokine expression in T cells. In line
herewith, a recent study identified the mouse IL-5 gene as a
direct LXR target gene with a putative LXR response element
in its promoter region [26]. The IL-5 gene lies in a Th2
cytokine locus that also encompasses the IL-4 and IL-13
gene, located on mouse chromosome 11qB1.3 and human
chromosome 5q31.1. These type 2 cytokine-encoding genes
have been shown to be regulated in a coordinate
manner [27–29]. Further research will be needed to verify
to what extent LXR transcription factor activity directly
regulates the expression of type 2 cytokine-encoding genes
and hereby promotes the development of type 2 cytokine-
driven eosinophilic inflammation in allergen sensitized
individuals.
Although not explored in this study, modulation by LXR-
activity of the eicosanoid pathway is another potential
mechanism through which LXR might exacerbate eosino-
philic airway inflammation in allergen-sensitized mice. In
macrophages, LXRs have been shown to induce the
expression of several genes mediating the synthesis of long-
chain polyunsaturated fatty acids, including arachidonic
acid [30]. Innate immune cells like macrophages may react to
enrichment in arachidonic acid of membrane phospholipids
by an increment in the production of eicosanoid lipid
inflammatory mediators [31]. Thus increased production of
lipid mediators may contribute to the pro-inflammatory
function of LXR activity in allergen-exposed mice.
In a broader context, our results indicate that LXR activity
may underlie the positive association found in several
epidemiological studies between elevated cholesterol levels
in the blood and asthma symptom severity [4–10].
Hypercholesterolemia as a result of high cholesterol diet
increases the availability of oxidized cholesterol derivatives
serving as LXR agonists and hence LXR transcriptional
activity. It is noteworthy in this context that mice deficient
in LXR activity do not show any difference in plasma
cholesterol levels and accordingly are not naturally hyper-
or hypocholesterolemic [22]. Our study implies that while
LXR activation promotes removal of excess cholesterol
through reverse cholesterol transport, it might also be
responsible for exacerbating asthma symptoms by enhanc-
ing type 2 cytokine expression from allergen-specific
T-cells, thereby mediating increased airway inflammation
similar to the inflammatory features we observed in
LXR agonist-treated WT mice. These findings are highly
relevant due to the increasing prevalence of asthma in
developed and developing countries where hypercholes-
terolemia is rising as well.
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Figure S1. Gating strategy of flow cytometry-based
differential cell counting on BAL cells. Singlet cells were
gated based on forward and side scatter. T cells were gated
as CD3þ autofluorescent cells and further subdivided
in CD4þ T cells and CD8þ T cells based on the respective
surface markers. Subsequent NOT gates were used to
identify alveolar macrophages, which were identified as
CD11cþ autofluorescentþ cells, eosinophils as SiglecFþ
CCR3þ cells, and neutrophils as CD11bþ Ly6Gþ.
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